Navigation Links
Flu Widespread in U.S., but Vaccine Is Poor Match
Date:2/15/2008

Even though shot misses 2 strains found, health officials still recommend inoculation

FRIDAY, Feb. 15 (HealthDay News) -- Widespread flu activity now exists in virtually every state, and many of the infections are being caused by some strains not covered by this year's influenza vaccine, U.S. health officials said Friday.

"After relatively low levels of influenza activity in the early part of the season, since January, influenza activity has been picking up in the nation," Dr. Joe Bresee, chief of the branch of epidemiology and prevention at the U.S. Centers for Disease Control and Prevention's Influenza Division, said during a teleconference.

"This season, we are seeing more disease out there and higher rates of hospitalizations and deaths than we've seen in the last couple of years," Bresee added.

Much of the increased activity owes to the fact that this year's flu vaccine isn't a match for some of the strains currently circulating in the United States, and some strains are becoming resistant to a common antiviral medication. The CDC reported last week that this year's flu vaccine doesn't match two of the three strains of influenza circulating in the United States.

"Slightly more than half of the viruses that we are looking at in our lab are viruses that are different than the vaccine strain," Bresee said. "So, they may not be well covered by the vaccine."

The virus strain most common in the United States right now is the influenza A H3N2 strain, and it's one strain not included in this year's vaccine. Also, this year's vaccine is not well matched against influenza type B, Bresee said.

The World Health Organization announced Thursday its recommendation for next year's flu vaccine, and it includes vaccine against the H3N2 strain and other strains not in this year's vaccine, Bresee said.

Complicating matters, some of this year's influenza type A virus is showing resistance to the antiviral drug Tamiflu. Overall, 8.1 percent of the influenza type A viruses tested by the CDC are resistant to Tamiflu. In past years, less than 1 percent of the viruses have been resistant to the drug, Bresee said.

"This represents a real increase in resistance," he said.

Forty-four states reported widespread flu activity this week, up from 31 last week. And, as of Feb. 9, 10 children have died from influenza this year.

"This is not particularly unexpected," Bresee said. "We may see more pediatric deaths before the season is finished."

The children ranged in age from 4 months to 14 years. During the last three years, flu-related deaths among children have ranged from 46 to 74, Bresee said.

Even though this year's vaccine isn't a good match for most of the circulating flu virus, the CDC continues to recommend that people get inoculated. The reason: The vaccine still offers partial protection and can reduce the risk of flu-related complications.

An estimated 5 percent to 20 percent of the U.S. population suffers from the flu each year. More than 200,000 people are hospitalized from flu complications, and about 36,000 people die from the disease. Some people, such as older individuals, young children, and people with certain health conditions (such as asthma, diabetes or heart disease), are at high risk for serious flu complications, according to the CDC.

More information

For more on flu, visit the CDC.



SOURCES: Feb. 15, 2008, teleconference with Joe Bresee, M.D., Branch Chief, Branch of Epidemiology and Prevention, U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta; Feb. 15, 2008, CDC, early release, Morbidity and Mortality Weekly Report


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
2. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
3. Study finds widespread vitamin and mineral use among cancer survivors
4. Report Finds Widespread Steroid Use in Baseball
5. Survey Reveals Widespread Lack of Communication With Doctors About Memory Concerns
6. Drug-Resistant Staph a Widespread Threat
7. Human rights violations widespread in eastern Burma
8. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
9. AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity
10. Vaccine for stomach flu may be possible, UNC research shows
11. Vaccine Could Cut Bouts With Stomach Flu
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flu Widespread in U.S.,  but Vaccine Is Poor Match
(Date:2/20/2017)... ... February 20, 2017 , ... ... as an employee health benefit for companies that want to help members of ... providers, employees will have access to Watson’s suite of oncology offerings for insights ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... result in better care, and MEDfx and the Delaware Health Information Network (DHIN) ... , As the nation’s first state-wide health information exchange, DHIN stores and shares ...
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/17/2017)... ... February 17, 2017 , ... While ... Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue while ... Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus host ... 2016-2021 and CAGR of 3% from 2021-2027. The market is expected to ... is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in ... How this report will ... future business opportunities emerging in this sector. In this brand ...
(Date:2/19/2017)...  nThrive™, an independent Patient-to-Payment? solutions company will ... at the 2017 HIMSS Conference. The company will ... KLAS. nThrive will host a Lunch ... trends shape the holistic, integrated revenue cycle of ... Access solution. The panel will reveal how health ...
(Date:2/19/2017)... and ORLANDO, Fla. , Feb. ... NKTR ) today announced that positive Phase 1 clinical ... with renal cell carcinoma (RCC) were presented at ASCO ... to expand specific cancer-fighting T cells and Natural Killer ... increase expression of PD-1 on these immune cells.  The ...
Breaking Medicine Technology: